If this can be demonstrated to be true, then our findings have potential to be exploited in cancer therapy where apoptosis of TS inhibitor-resistant tumour cells can be optimized by chemotherapeutically targeting pyrimidine salvage enzymes such as thymidine kinase, thus providing a synergistic impact. This evidence concerns the gene TYMS and neoplasm.